Manhattan Bridge Capital, Inc. Reports Third Quarter Results for 2026
Nine-month operating cash flow increased to $4,026,477 from $3,806,024 despite lower earnings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Manhattan Bridge Capital (Nasdaq: LOAN) reported third-quarter 2026 net income of $1,238,462, an increase from the same period last year. Revenue for the three months ended September 30 rose 0.9% to $2,053,558, while net income increased 3.0%. Basic and diluted earnings per share remained $0.11. Higher origination fees and lower financing expenses offset lower interest income and higher administrative expenses.
For the nine months ended September 30, revenue fell 7.5% to $6,166,405, and net income declined 8.1% to $3,665,433. Basic and diluted earnings per share decreased to $0.32 from $0.35. On October 8, the board increased its repurchase authorization from 100,000 to 250,000 shares and extended it through October 8, 2027. At September 30, loans receivable, net of deferred fees, were $59,478,735, and shareholders’ equity was $42,789,479.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointThird-quarter net income increased 3.0% to $1,238,462; basic and diluted EPS remained $0.11 year over year.
- Moderate pointThird-quarter revenue rose 0.9% to $2,053,558 from $2,035,753 a year earlier.
- Moderate pointNine-month operating cash flow increased to $4,026,477 from $3,806,024 a year earlier.
- Moderate pointRepurchase authorization increased from 100,000 to 250,000 shares, with the program extended through October 8, 2027.
- Minor pointThird-quarter origination fees increased to $391,662 from $265,376 a year earlier.
5 minor points
- Minor pointThird-quarter financing expenses decreased to $369,477 from $421,980 a year earlier, including deferred financing cost amortization.
- Minor pointNine-month financing expenses decreased to $1,131,684 from $1,379,595 a year earlier, including deferred financing cost amortization.
- Minor pointNine-month repurchases returned $219,339 to shareholders through purchases of 54,985 shares.
- Minor pointLines of credit outstanding declined to $17,034,621 at September 30, 2026, from $17,601,132 at December 31, 2025.
- Minor pointNine-month short-term loan issuance increased to $40,832,273 from $27,957,494 a year earlier.
Negative
- Moderate pointNine-month net income fell 8.1% to $3,665,433; basic and diluted EPS declined to $0.32 from $0.35.
- Moderate pointNine-month revenue declined 7.5% to $6,166,405 from $6,664,702 a year earlier.
- Minor pointNine-month interest income decreased to $5,099,291 from $5,503,694 a year earlier.
- Minor pointNine-month origination fees decreased to $1,067,114 from $1,161,008 a year earlier.
- Minor pointThird-quarter interest income declined to $1,661,896 from $1,770,377 a year earlier.
7 minor points
- Minor pointThird-quarter general and administrative expenses increased to $447,275 from $413,518 a year earlier.
- Minor pointNine-month general and administrative expenses increased to $1,373,033 from $1,304,873 a year earlier.
- Minor pointNine-month referral fees increased to $8,455 from $4,242; third-quarter fees rose to $2,844 from $2,575.
- Minor pointNet loans receivable declined to $59,478,735 at September 30, 2026, from $60,218,841 at December 31, 2025.
- Minor pointShareholders’ equity declined to $42,789,479 at September 30, 2026, from $43,099,544 at December 31, 2025.
- Minor pointCash and restricted cash decreased $51,396 during the first nine months of 2026, ending at $176,843.
- Minor pointDeferred financing costs incurred were $64,816 in the first nine months of 2026, versus none a year earlier.
News Explained
By
Key Figures
- Q3 revenue
- $2,053,558; +0.9% YoY
- Three months ended September 30, 2026
- Q3 net income
- $1,238,462; +3.0% YoY
- Three months ended September 30, 2026
- Q3 diluted EPS
- $0.11
- Three months ended September 30, 2026; unchanged from 2025
- Nine-month revenue
- $6,166,405; -7.5% YoY
- Nine months ended September 30, 2026
- Nine-month net income
- $3,665,433; -8.1% YoY
- Nine months ended September 30, 2026
- Nine-month diluted EPS
- $0.32 vs. $0.35
- Nine months ended September 30, 2026 vs. 2025
- Share repurchase authorization
- 250,000 shares; extended through October 8, 2027
- Amended program increased from 100,000 shares and extended 12 months
Previous Earnings Reports
-
Q2 revenue and net income fell year over year amid lower rates and origination fees.
-
Q3 revenue and net income declined year over year as interest income and origination fees fell.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
origination fees financial
deferred financing costs financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
GREAT NECK, N.Y., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its total revenues for the three months ended September 30, 2026 were approximately
Net income for the three months ended September 30, 2026 was approximately
Total revenues for the nine months ended September 30, 2026 were approximately
Net income for the nine months ended September 30, 2026 was approximately
As of September 30, 2026, total shareholders' equity was approximately
On November 20, 2025, the Company’s board of directors authorized a share repurchase program authorizing the repurchase of up to 100,000 shares of the Company’s common stock in the next twelve months. As of September 30, 2026, the Company had repurchased an aggregate of 61,185 shares under the program at a total cost of approximately
On October 8, 2026, the Company’s board of directors approved an amendment to the existing share repurchase program, increasing the aggregate number of shares authorized for repurchase from 100,000 to 250,000 shares and extending the program for an additional 12 months, through October 8, 2027.
Assaf Ran, Chairman of the Board and Chief Executive Officer of the Company, stated, “The increasing interest rate environment is raising pressure on the real estate markets, rent-to-mortgage-payment ratios are getting tighter, and sales are lingering as fewer buyers qualify for loans. Yet, unexpectedly, hard money rates haven’t increased much at this point due to intense competition. The facts that we’re exceptionally low leveraged and conservative are beneficial during these times.”
About Manhattan Bridge Capital, Inc.
Manhattan Bridge Capital, Inc. offers short-term secured, non–banking loans (sometimes referred to as ‘‘hard money’’ loans) to real estate investors to fund their acquisition, renovation, rehabilitation or development of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The Company operates the website: https://www.manhattanbridgecapital.com.
Forward-Looking Statements
This press release and statements made by the Company’s representatives in connection with this press release contain, or may contain, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” and “continue,” and similar expressions, are intended to identify forward-looking statements.
Forward-looking statements in this press release include, among other things, statements regarding the future lending activity, competitive conditions, and interest rates. Readers are cautioned that forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected, expressed or implied in such forward-looking statements as a result of various factors, including, but not limited to: (i) our loan origination activities, revenues and profits are limited by available funds; (ii) we operate in a highly competitive market and competition may limit our ability to originate loans with favorable interest rates and fees; (iii) our Chief Executive Officer is critical to our business and our future success may depend on our ability to retain him; (iv) if we overestimate the yields on our loans or the amounts recoverable through foreclosure, or incorrectly value the collateral securing our loans, we may experience losses; (v) we may be subject to “lender liability” claims; (vi) our due diligence may not uncover all of a borrower’s liabilities or other risks to its business; (vii) borrower concentration could lead to significant losses; (viii) we may choose to make distributions in our own stock, in which case shareholders may be required to pay income taxes in excess of the cash dividends they receive; and (ix) an increase in interest rates may affect our profitability. The risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission, identify additional important factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements. These forward-looking statements speak only as of the date of this press release. Except as required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
| MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS | |||||||
| Assets | September 30, 2026 (unaudited) | December 31, 2025 (audited) | |||||
| Loans receivable, net of deferred origination and other fees | $ | 59,478,735 | $ | 60,218,841 | |||
| Interest and other fees receivable on loans | 1,566,838 | 1,642,825 | |||||
| Cash | 168,093 | 204,889 | |||||
| Cash – restricted | 8,750 | 23,350 | |||||
| Other assets | 88,508 | 60,742 | |||||
| Right-of-use asset – operating lease, net | 61,616 | 101,226 | |||||
| Deferred financing costs, net | 107,000 | 98,858 | |||||
| Total assets | $ | 61,479,540 | $ | 62,350,731 | |||
| Liabilities and Stockholders’ Equity | |||||||
| Liabilities: | |||||||
| Lines of credit | $ | 17,034,621 | $ | 17,601,132 | |||
| Accounts payable and accrued expenses | 170,734 | 173,247 | |||||
| Operating lease liability | 69,274 | 112,076 | |||||
| Loan holdback | 164,598 | 50,000 | |||||
| Dividends payable | 1,250,834 | 1,314,732 | |||||
| Total liabilities | 18,690,061 | 19,251,187 | |||||
| Commitments and contingencies | |||||||
| Stockholders’ equity: | |||||||
| Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding | --- | --- | |||||
| Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,377,466 and 11,432,451 outstanding, respectively | 11,757 | 11,757 | |||||
| Additional paid-in capital | 45,583,716 | 45,575,006 | |||||
| Less: Treasury shares, at cost – 379,592 and 324,607 shares, respectively | (1,318,303 | ) | (1,098,964 | ) | |||
| Accumulated deficit | (1,487,691 | ) | (1,388,255 | ) | |||
| Total stockholders’ equity | 42,789,479 | 43,099,544 | |||||
| Total liabilities and stockholders’ equity | $ | 61,479,540 | $ | 62,350,731 | |||
| MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenue: Interest income from loans | $ | 1,661,896 | $ | 1,770,377 | $ | 5,099,291 | $ | 5,503,694 | |||||||
| Origination fees | 391,662 | 265,376 | 1,067,114 | 1,161,008 | |||||||||||
| Total revenue | 2,053,558 | 2,035,753 | 6,166,405 | 6,664,702 | |||||||||||
| Operating costs and expenses: | |||||||||||||||
| Interest and amortization of deferred financing costs | 369,477 | 421,980 | 1,131,684 | 1,379,595 | |||||||||||
| Referral fees | 2,844 | 2,575 | 8,455 | 4,242 | |||||||||||
| General and administrative expenses | 447,275 | 413,518 | 1,373,033 | 1,304,873 | |||||||||||
| Total operating costs and expenses | 819,596 | 838,073 | 2,513,172 | 2,688,710 | |||||||||||
| Income from operations | 1,233,962 | 1,197,680 | 3,653,233 | 3,975,992 | |||||||||||
| Other income | 4,500 | 4,500 | 13,500 | 13,500 | |||||||||||
| Income before income tax expense | 1,238,462 | 1,202,180 | 3,666,733 | 3,989,492 | |||||||||||
| Income tax expense | --- | --- | (1,300 | ) | (1,210 | ) | |||||||||
| Net income | $ | 1,238,462 | $ | 1,202,180 | $ | 3,665,433 | $ | 3,988,282 | |||||||
| Basic and diluted net income per common share outstanding: | |||||||||||||||
| --Basic | $ | 0.11 | $ | 0.11 | $ | 0.32 | $ | 0.35 | |||||||
| --Diluted | $ | 0.11 | $ | 0.11 | $ | 0.32 | $ | 0.35 | |||||||
| Weighted average number of common shares outstanding: | |||||||||||||||
| --Basic | 11,410,412 | 11,438,651 | 11,422,745 | 11,438,651 | |||||||||||
| --Diluted | 11,410,412 | 11,438,651 | 11,422,745 | 11,438,651 | |||||||||||
| MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (unaudited) | ||||||||
| FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 | ||||||||
| Common Shares | Additional Paid in Capital | Treasury Shares | Accumulated Deficit | Totals | ||||
| Shares | Amount | Shares | Cost | |||||
| Balance, July 1, 2026 | 11,757,058 | $11,757 | $45,581,538 | 331,549 | $(1,129,013) | $(1,475,319) | $42,988,963 | |
| Non-cash compensation | 2,178 | 2,178 | ||||||
| Purchase of treasury shares | 48,043 | (189,290) | (189,290) | |||||
| Dividends declared and payable | (1,250,834) | (1,250,834) | ||||||
| Net income | ________ | ______ | __________ | ______ | __________ | 1,238,462 | 1,238,462 | |
| Balance, September 30, 2026 | 11,757,058 | $11,757 | $45,583,716 | 379,592 | $(1,318,303) | $(1,487,691) | $42,789,479 | |
| FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025 | |||||||||
| Common Shares | Additional Paid in Capital | Treasury Shares | Accumulated Deficit | Totals | |||||
| Shares | Amount | Shares | Cost | ||||||
| Balance, July 1, 2025 | 11,757,058 | $11,757 | $45,568,473 | 318,407 | $(1,070,406) | $(1,082,953) | $43,426,871 | ||
| Non-cash compensation | 3,266 | 3,266 | |||||||
| Dividends declared and payable | (1,315,445) | (1,315,445) | |||||||
| Net income | ________ | ______ | __________ | ______ | __________ | 1,202,180 | 1,202,180 | ||
| Balance, September 30, 2025 | 11,757,058 | $11,757 | $45,571,739 | 318,407 | $(1,070,406) | $(1,196,218) | $43,316,872 | ||
| FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 | ||||||||
| Common Shares | Additional Paid in Capital | Treasury Shares | Accumulated Deficit | Totals | ||||
| Shares | Amount | Shares | Cost | |||||
| Balance, January 1, 2026 | 11,757,058 | $11,757 | $45,575,006 | 324,607 | $(1,098,964) | $ (1,388,255) | $43,099,544 | |
| Non-cash compensation | 8,710 | 8,710 | ||||||
| Purchase of treasury shares | 54,985 | (219,339) | (219,339) | |||||
| Dividends paid | (2,514,035) | (2,514,035) | ||||||
| Dividends declared and payable | (1,250,834) | (1,250,834) | ||||||
| Net income | ________ | ______ | _________ | ______ | __________ | 3,665,433 | 3,665,433 | |
| Balance, September 30, 2026 | 11,757,058 | $11,757 | $45,583,716 | 379,592 | $(1,318,303) | $(1,487,691) | $42,789,479 | |
| FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 | |||||||
| Common Shares | Additional Paid in Capital | Treasury Shares | Accumulated Deficit | Totals | |||
| Shares | Amount | Shares | Cost | ||||
| Balance, January 1, 2025 | 11,757,058 | $11,757 | $45,561,941 | 318,407 | $(1,070,406) | $(1,238,165) | $43,265,127 |
| Non-cash compensation | 9,798 | 9,798 | |||||
| Dividends paid | (2,630,890) | (2,630,890) | |||||
| Dividends declared and payable | (1,315,445) | (1,315,445) | |||||
| Net income | ________ | ______ | __________ | ______ | __________ | 3,988,282 | 3,988,282 |
| Balance, September 30, 2025 | 11,757,058 | $11,757 | $45,571,739 | 318,407 | $(1,070,406) | $(1,196,218) | $43,316,872 |
| MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) | ||||||||
| Nine Months Ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net income | $ | 3,665,433 | $ | 3,988,282 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities - | ||||||||
| Amortization of deferred financing costs | 56,675 | 66,710 | ||||||
| Adjustment to right-of-use asset - operating lease and liability | (3,191 | ) | (1,459 | ) | ||||
| Depreciation | 1,281 | 4,007 | ||||||
| Non-cash compensation expense | 8,710 | 9,798 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Interest and other fees receivable on loans | 75,987 | (70,895 | ) | |||||
| Other assets | (29,049 | ) | (69,940 | ) | ||||
| Accounts payable and accrued expenses | (2,513 | ) | (60,678 | ) | ||||
| Deferred origination and other fees | 138,546 | (59,801 | ) | |||||
| Proceeds from borrower escrow deposits – loan holdback | 114,598 | --- | ||||||
| Net cash provided by operating activities | 4,026,477 | 3,806,024 | ||||||
| Cash flows from investing activities: | ||||||||
| Issuance of short-term loans | (40,832,273 | ) | (27,957,494 | ) | ||||
| Collections received from loans | 41,433,833 | 35,474,993 | ||||||
| Purchase of fixed assets | --- | (418 | ) | |||||
| Net cash provided by investing activities | 601,560 | 7,517,081 | ||||||
| Cash flows from financing activities: | ||||||||
| Repayment of lines of credit | (43,901,366 | ) | (40,751,845 | ) | ||||
| Proceeds from lines of credit | 43,334,855 | 33,373,595 | ||||||
| Dividends paid | (3,828,767 | ) | (3,946,335 | ) | ||||
| Purchase of treasury shares | (219,339 | ) | --- | |||||
| Deferred financing costs incurred | (64,816 | ) | --- | |||||
| Net cash used in financing activities | (4,679,433 | ) | (11,324,585 | ) | ||||
| Net decrease in cash and restricted cash | (51,396 | ) | (1,480 | ) | ||||
| Cash and restricted cash, beginning of period(1) | 228,239 | 201,762 | ||||||
| Cash and restricted cash, end of period(2) | $ | 176,843 | $ | 200,282 | ||||
| Supplemental Disclosure of Cash Flow Information: | ||||||||
| Cash paid during the period for taxes | $ | 1,300 | $ | 1,210 | ||||
| Cash paid during the period for interest | $ | 1,074,078 | $ | 1,346,361 | ||||
| Cash paid during the period for operating leases | $ | 49,454 | $ | 47,973 | ||||
| Supplemental Schedule of Noncash Financing Activities: | ||||||||
| Dividend declared and payable | $ | 1,250,834 | $ | 1,315,445 | ||||
| Supplemental Schedule of Noncash Operating and Investing Activities: | ||||||||
| Reduction in interest receivable in connection with the increase in loans receivable | $ | --- | $ | 13,122 | ||||
(1) At December 31, 2025 and 2024, cash and restricted cash included
(2) At September 30, 2026 and 2025, cash and restricted cash included
Contact:
Assaf Ran, CEO
(516) 444-3400
www.linkedin.com/in/assafran
SOURCE: Manhattan Bridge Capital, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Manhattan Bridge Capital’s third-quarter 2026 earnings?
Manhattan Bridge Capital earned $1,238,462 in the three months ended September 30, 2026, up 3.0% from $1,202,180 a year earlier. Basic and diluted earnings per share remained $0.11. Revenue increased 0.9% to $2,053,558.
Why did Manhattan Bridge Capital’s nine-month 2026 revenue decline?
The company attributed the decline primarily to lower interest rates and origination fees charged to borrowers because of increased competition. Revenue decreased despite increases in both the number of loans originated and the amount of capital deployed.